Literature DB >> 24906535

[Driving ability with affective disorders and under psychotropic drugs].

G Laux1, A Brunnauer.   

Abstract

There are only few data available regarding the effects of depressive disorders on road safety due to methodological shortcomings. Patients with acute severe depression or manias are unqualified for driving but after clinical remission driving ability can be attested under psychiatric supervision in most cases. So far there are only few data available about a patient's fitness to drive under psychotropic medication. Regarding the effects of antidepressants on road safety depressed patients obviously benefit from treatment with newer antidepressants; however, at least some subgroups of patients do not reach the performance level of healthy subjects. Approximately 17 % of remission bipolar patients must be regarded as unable to drive and 27 % of patients with schizophrenia on discharge from hospital. Benzodiazepines are clearly associated with increased risk of road traffic accidents. Impaired driving ability of young attention deficit hyperactivity disorder (ADHS) patients is improved under treatment with methylphenidate. Counselling patients with respect to driving ability must be carried out individually taking into account factors of the illness, personality, attitudes and coping strategies as well as different psychopharmacological effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906535     DOI: 10.1007/s00115-013-3994-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

Review 1.  Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

Authors:  Johannes G Ramaekers
Journal:  J Clin Psychiatry       Date:  2003-01       Impact factor: 4.384

2.  Self-destruction in Finnish motor traffic accidents in 1974-1992.

Authors:  K Hernetkoski; E Keskinen
Journal:  Accid Anal Prev       Date:  1998-09

3.  Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine.

Authors:  Felix M Segmiller; Igor Hermisson; Michael Riedel; Florian Seemüller; Thomas Volkamer; Gerd Laux; Hans-Jürgen Möller; Alexander Brunnauer
Journal:  J Clin Pharmacol       Date:  2013-02-20       Impact factor: 3.126

4.  Antidepressants and driving ability: results from a clinical study.

Authors:  Alexander Brunnauer; Gerd Laux; Elisabeth Geiger; Michael Soyka; Hans-Jürgen Möller
Journal:  J Clin Psychiatry       Date:  2006-11       Impact factor: 4.384

5.  Suicidal ideation, antidepressive medication and car crash injury.

Authors:  Lawrence T Lam; Robyn Norton; Jennie Connor; Shanthi Ameratunga
Journal:  Accid Anal Prev       Date:  2005-03

6.  The effects of chronic lithium treatment on psychomotor performance related to driving.

Authors:  S Hatcher; R Sims; D Thompson
Journal:  Br J Psychiatry       Date:  1990-08       Impact factor: 9.319

Review 7.  [Psychiatric disorders and fitness to drive an automobile. An overview].

Authors:  G Laux
Journal:  Nervenarzt       Date:  2002-03       Impact factor: 1.214

Review 8.  Cognitive impairment in euthymic major depressive disorder: a meta-analysis.

Authors:  E Bora; B J Harrison; M Yücel; C Pantelis
Journal:  Psychol Med       Date:  2012-10-26       Impact factor: 7.723

9.  The impact of antipsychotics on psychomotor performance with regards to car driving skills.

Authors:  Alexander Brunnauer; Gerd Laux; Elisabeth Geiger; Hans-Jürgen Möller
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

Review 10.  Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.

Authors:  Roger S McIntyre; Danielle S Cha; Joanna K Soczynska; Hanna O Woldeyohannes; Laura Ashley Gallaugher; Paul Kudlow; Mohammad Alsuwaidan; Anusha Baskaran
Journal:  Depress Anxiety       Date:  2013-03-06       Impact factor: 6.505

View more
  1 in total

1.  Neuropsychological exponents for the driving ability in remitted bipolar patients.

Authors:  Piotr Joachimiak; Krystyna Jaracz; Jan Jaracz
Journal:  Int J Bipolar Disord       Date:  2022-01-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.